MetaCap

Definitive Healthcare Corp. Class A (DH)

NASDAQ: DHTechnologyComputer Software: Prepackaged SoftwareUSD

1.20-0.01 (-0.83%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

DH stock chart

Technical analysis

Key statistics

All statistics
Market cap
$128.60M
EPS (TTM)
-$1.50
52-week range
0.61 – 3.00
Day range
1.14 – 1.24
Volume / Avg
389.93K / 682.42K
Beta
—

52-week range

$0.61$3.00

DH stock today

On Nov 20, DH ended the session at $1.20, shedding $0.01 (0.83%), versus the S&P 500's 3.70% decline. At this level, DH sits in the middle of its 52-week range of $0.61 to $3.00: 60.0% below the high, set on Nov 28, 2025 and 96.7% above the low. DH is down 58.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 56.5%.

Definitive Healthcare has posted a net loss over the last twelve months (EPS of -$1.50), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Definitive Healthcare

Company profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management.

Industry
Computer Software: Prepackaged Software
CEO
Mr. Clay Ritchey
Headquarters
Framingham, MA
Employees
678
IPO year
2021

Financial highlights

Full financials

In fiscal 2025, Definitive Healthcare generated $241.5 million in revenue, down 4.2% from fiscal 2024, the first decline in the 6 years shown. Definitive Healthcare reported a net loss of $138.9 million, compared with a loss of $413.1 million a year earlier. Gross margin was 75.9% (down from 78.3%) and operating margin -92.9%.

Definitive Healthcare annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$241.52M$252.20M$251.41M$222.65M$166.15M
Growth-4.24%+0.31%+12.92%+34.00%+40.43%
Net income$-138.93M$-413.12M$-202.39M$-7.22M$-17.84M
EPS (diluted)$-1.30$-3.54$-1.79$-0.07$-0.19

Analyst forecast

Forecast

Consensus (6 analysts)

hold

Avg. price target

$1.63+35.83%

  • Strong buy 0
  • Buy 1
  • Hold 4
  • Sell 0
  • Strong sell 1

Target range

Low $1.00High $3.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 5, 2026
EPS actual vs est.
$-0.04 vs $0.01
Surprise
-500.00%

DH news

All DH news

Definitive Healthcare peers

Technology sector
DH peer companies
CompanyPrice% ChgMarket capCompare
AEYEAudioEye Inc.10.41-0.57%$132.05Mvs DH
EXFYExpensify Inc. Class A1.45-7.64%$133.97Mvs DH
SWMRSwarmer Inc6.95-12.36%$134.85Mvs DH
PDYNPalladyne AI Corp.2.37-12.55%$121.58Mvs DH
EGANeGain Corporation5.59-3.62%$140.99Mvs DH
HUCKHuckleberry.ai Inc. Class B3.05-4.39%$143.46Mvs DH
GRRRGorilla Technology Group Inc.5.26-16.32%$144.93Mvs DH
INSEInspired Entertainment Inc.3.63-1.63%$95.71Mvs DH

Indexes, lists and sector

Definitive Healthcare stock FAQ

What is Definitive Healthcare's stock price today?

DH last traded at $1.20 as of Nov 20, 4:00 PM EST, down 0.83% on the day. Prices are delayed at least 15 minutes.

Who is Definitive Healthcare's CEO?

Mr. Clay Ritchey is the chief executive officer of Definitive Healthcare Corp. Class A, which has about 678 employees.

What is the DH 52-week high?

The 52-week high for DH is $3.00 and the 52-week low is $0.61. The stock is currently 60.0% below its high.

Compare DH